Seth Lederman
2013
In 2013, Seth Lederman earned a total compensation of $1.1M as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $277,500 |
|---|---|
| Option Awards | $528,525 |
| Other | $265,625 |
| Total | $1,071,650 |
Lederman received $528.5K in option awards, accounting for 49% of the total pay in 2013.
Lederman also received $277.5K in bonus and $265.6K in other compensation.
Rankings
In 2013, Seth Lederman's compensation ranked 6,290th out of 12,286 executives tracked by ExecPay. In other words, Lederman earned more than 48.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,290 out of 12,286 | 49th |
Division Manufacturing | 2,200 out of 4,612 | 52nd |
Major group Chemicals And Allied Products | 654 out of 1,462 | 55th |
Industry group Drugs | 474 out of 1,156 | 59th |
Industry Pharmaceutical Preparations | 378 out of 890 | 58th |
Source: SEC filing on March 25, 2016.
Lederman's colleagues
We found two more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2013.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019